To comply with federal, state, and local regulations and guidelines, the UCLA Institutional Biosafety Committee in coordination with the Office of Environment, Health & Safety, Biosafety Program facilitates reporting of incidents involving biohazard material and recombinant DNA for all UCLA research or teaching related activities on or off the campus. Biohazard materials includes: recombinant DNA, infectious organisms including zoonotic materials and biological toxins, and all human materials (including cells, tissues, and bodily fluids).
Immediate and accurate reporting involving biohazard material is important in identifying potentially hazardous operations and procedures including potential noncompliance. This policy has been adopted to initiate the necessary information gathering to determine the nature and extent of the incident as well as assess the effectiveness of the assigned containment and safety practices, corrective actions, and other remediation.
This policy is the minimum reporting requirements and doesn’t cover incident response such as, but not limited to, spill or exposure requiring medical attention and/or post-exposure treatment. Incidents involving select biological agents and toxins or human gene transfer research must comply with the reporting requirements specific to those regulations.
This is not an exhaustive list, but a sampling of what is reportable:
|How?||Contact EH&S Hotline: (310) 825-9797|
- NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (NIH Guidelines), April 2016
- CDC Biosafety in Microbiological and Biomedical Laboratories, 5th Edition
- Cal/OSHA California Code of Regulations Title 8 General Safety Orders – all relevant sections
- HHS/CDC and USDA/APHIS 42 CFR 73, 9 CFR 121, and 7 CFR 331
- OSP - Do adverse events experienced by participants in human gene transfer trials fall under this incident reporting requirement?
Approved 6/24/10; Revised 7/29/11